ANTICANCER STUDIES OF ZERUMBONE-LOADED CHITOSAN-OLEIC ACID NANOPARTICLES AGAINST T47D BREAST CANCER CELLS
DOI:
https://doi.org/10.22159/ijap.2024.v16s6.TY2036Keywords:
Cytotoxic, Nanoparticles, Zerumbone, Chitosan, T47D cellsAbstract
Objective: The phytochemical compound zerumbone is derived from the rhizome of Zingiber zerumbet (L.) Smith. Nanotechnology-based drug delivery system employing chitosan-oleic acid nanoparticles to transport zerumbone. This study aimed to examine the cytotoxic activity of zerumbone nanoparticles against T47D breast cancer cells.
Methods: Using the ionic gelation method, zerumbone-loaded chitosan-oleic acid nanoparticles were synthesized and characterized for particle size, zeta potential, morphology, and encapsulation efficiency. Utilizing the MTT assay, flow cytometry, and confocal microscopy, the cytotoxic activity of nanoparticles was evaluated.
Results: The characterization of zerumbone nanoparticles resulted in a particle size of 116±12.04 nm, polydispersity index of 0.74±0.07 μm, and zeta potential of (+34.4) mV. HPLC analysis showed an encapsulation efficiency of 92.43±1.73%. The uptake of zerumbone-loaded chitosan-oleic acid nanoparticles into T47D cells induced higher apoptosis than the zerumbone isolate and the control nanoparticles.
Conclusion: Zerumbone-loaded chitosan-oleic acid nanoparticles showed anticancer activity against breast cancer cells T47D. Using nanoparticles as a drug delivery system would improve the clinical efficacy of anticancer treatment, which has significant implications for future cancer treatment strategies.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660, PMID 33538338.
Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323, PMID 30667505.
Yuliani R, Syahdeni F. Cytotoxicity of ethanolic extract of papaya leaves (Carica papaya) and its fractions on T47D cells. Pharmacon J Farmasi Indones. 2020;17(1):17-23. doi: 10.23917/pharmacon.v17i1.10760.
Nabilla II, Indrayudha P. Aktivitas sitotoksik ekstrak etanol fraksi etanol etil-asetat dan heksana kulit jeruk purut (Citrus hystrix dc.) terhadap sel kanker payudara T47D. Pharmacon J Farmasi Indones. 2019 Jul 15;16(1):11-7. doi: 10.23917/pharmacon.v16i1.8173.
Srivastava AK, Srivastava SK, Shah NC. Essential oil composition of Zingiber zerumbet (L.) Sm. From India. J Essent Oil Res. 2000 Sep 1;12(5):595-7. doi: 10.1080/10412905.2000.9712165.
Chan ML, Liang JW, HSU LC, Chang WL, Lee SS, Guh JH. Zerumbone a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(11):1223-36. doi: 10.1007/s00210-015-1152-z, PMID 26246051.
Hanwar D, Suhendi A, Trisharyanti I, Santoso B, Safitri M. Secondary metabolite profile analysis of lempuyang emprit extract by gas chromatography-mass spectroscopy. University Research Colloquium. 2015;1:158-66.
Dai M, Fadhilah A, Rahmawati J, Forentin AM, Usia T, Maryati M. T47D cell-inhibiting Indonesian medicinal plants and active constituents of Alpinia galanga rhizome. Pharmacogn Mag. 2018;14(56):359. doi: 10.4103/pm.pm_259_17.
Shamoto T, Matsuo Y, Shibata T, Tsuboi K, Nagasaki T, Takahashi H. Zerumbone inhibits angiogenesis by blocking NF-κB activity in pancreatic cancer. Pancreas. 2014 Apr 1;43(3):396-404. doi: 10.1097/MPA.0000000000000039, PMID 24622069.
Ibanez MD, Sanchez Ballester NM, Blazquez MA. Healthy zerumbone: from natural sources to strategies to improve its bioavailability and oral administration. Plants (Basel). 2022 Dec 20;12(1):5. doi: 10.3390/plants12010005, PMID 36616138.
Hassan MM, Mohammed AF, Elamin KM, Devkota HP, Ohno Y, Motoyama K. Improvement of pharmaceutical properties of zerumbone a multifunctional compound using cyclodextrin derivatives. Chem Pharm Bull (Tokyo). 2020 Nov 1;68(11):1117-20. doi: 10.1248/cpb.c20-00621, PMID 33132380.
Raikar PR, Dandagi PM. Functionalized polymeric nanoparticles: a novel targeted approach for oncology care. Int J App Pharm. 2021;13(6):1-18. doi: 10.22159/ijap.2021v13i6.42714.
Garg U, Chauhan S, Nagaich U, Jain N. Current advances in chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull. 2019 Jun;9(2):195-204. doi: 10.15171/apb.2019.023, PMID 31380245.
Wikantyasning ER, Andasari SD, Da’i M, Nabila A. Nanoencapsulation of zerumbone in oleic acid modified chitosan nanoparticles. ACM Int Conf Proceeding S. 2017:105-9. doi: 10.1145/3155077.3155097.
Kesharwani SS, Bhat GJ. Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone. Medicina (Kaunas). 2020;56(11):557. doi: 10.3390/medicina56110557, PMID 33114101.
Miele D, Rossi S, Sandri G, Vigani B, Sorrenti M, Giunchedi P. Chitosan oleate salt as an amphiphilic polymer for the surface modification of poly lactic glycolic acid (PLGA) nanoparticles preliminary studies of mucoadhesion and cell interaction properties. Mar Drugs. 2018 Nov 15;16(11):447. doi: 10.3390/md16110447, PMID 30445668.
Rahmawanty D, Anwar E, Bahtiar A. Utilization of cross linked chitosan with tripolyphosphate as an excipient for haruan fish gel. J Ilm Kefarmasian Indones. 2015;13(1):76-81.
Kumar A, Dixit CK. Methods for characterization of nanoparticles. Inadv Nanomed Deliv Ther Nucleic Acids. 2017:43-58. doi: 10.1016/B978-0-08-100557-6.00003-1.
Bhattacharjee S. DLS and zeta potential-what they are and what they are not? J Control Release. 2016 Aug 10;235:337-51. doi: 10.1016/j.jconrel.2016.06.017, PMID 27297779.
Rahman HS, Rasedee A, Abdul AB, Zeenathul NA, Othman HH, Yeap SK. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line. Int J Nanomedicine. 2014 Jan 16;9:527-38. doi: 10.2147/IJN.S54346, PMID 24549090.
Mohamad NE, Abu N, Rahman HS, KY H, HO WY, Lim KL. Nanostructured lipid carrier improved in vivo anti-tumor and immunomodulatory effect of zerumbone in 4T1 challenged mice. RSC Adv. 2015;5(28):22066-74. doi: 10.1039/C5RA00144G.
Carneiro BA, El Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. doi: 10.1038/s41571-020-0341-y, PMID 32203277.
Hosseinpour M, Abdul AB, Rahman HS, Rasedee A, Yeap SK, Ahmadi N. Comparison of the apoptotic inducing effect of zerumbone and zerumbone loaded nanostructured lipid carrier on human mammary adenocarcinoma MDA-MB-231 cell line. J Nanomater. 2014;2014(1):182. doi: 10.1155/2014/742738.
Published
How to Cite
Issue
Section
Copyright (c) 2024 ERINDYAH R WIKANTYASNING, ZULFA MAZIDAH, MUHAMMAD DA’I, IKA TD KUSUMAWATI, SUPRAPTO SUPRAPTO
This work is licensed under a Creative Commons Attribution 4.0 International License.